1. Home
  2. TCI vs VYGR Comparison

TCI vs VYGR Comparison

Compare TCI & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCI
  • VYGR
  • Stock Information
  • Founded
  • TCI 1983
  • VYGR 2013
  • Country
  • TCI United States
  • VYGR United States
  • Employees
  • TCI N/A
  • VYGR N/A
  • Industry
  • TCI Real Estate
  • VYGR Biotechnology: Pharmaceutical Preparations
  • Sector
  • TCI Finance
  • VYGR Health Care
  • Exchange
  • TCI Nasdaq
  • VYGR Nasdaq
  • Market Cap
  • TCI 248.2M
  • VYGR 177.2M
  • IPO Year
  • TCI N/A
  • VYGR 2015
  • Fundamental
  • Price
  • TCI $27.25
  • VYGR $3.49
  • Analyst Decision
  • TCI
  • VYGR Strong Buy
  • Analyst Count
  • TCI 0
  • VYGR 9
  • Target Price
  • TCI N/A
  • VYGR $14.86
  • AVG Volume (30 Days)
  • TCI 2.6K
  • VYGR 387.6K
  • Earning Date
  • TCI 05-08-2025
  • VYGR 05-12-2025
  • Dividend Yield
  • TCI N/A
  • VYGR N/A
  • EPS Growth
  • TCI N/A
  • VYGR N/A
  • EPS
  • TCI 0.68
  • VYGR N/A
  • Revenue
  • TCI $47,778,000.00
  • VYGR $80,001,000.00
  • Revenue This Year
  • TCI N/A
  • VYGR N/A
  • Revenue Next Year
  • TCI N/A
  • VYGR $2.04
  • P/E Ratio
  • TCI $40.79
  • VYGR N/A
  • Revenue Growth
  • TCI N/A
  • VYGR N/A
  • 52 Week Low
  • TCI $25.50
  • VYGR $2.75
  • 52 Week High
  • TCI $31.92
  • VYGR $9.55
  • Technical
  • Relative Strength Index (RSI)
  • TCI 41.23
  • VYGR 50.59
  • Support Level
  • TCI $27.69
  • VYGR $3.42
  • Resistance Level
  • TCI $28.23
  • VYGR $3.58
  • Average True Range (ATR)
  • TCI 0.49
  • VYGR 0.21
  • MACD
  • TCI -0.10
  • VYGR 0.08
  • Stochastic Oscillator
  • TCI 3.52
  • VYGR 85.22

About TCI Transcontinental Realty Investors Inc.

Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: